2020 Transactions with Related Persons
On February 26, 2020, Bruker closed a purchase and sale agreement to acquire the land and buildings located at 15 Fortune Drive and 44
Manning Road, both in Billerica, MA, for a total purchase price of $12.3 million, from a trust controlled equally by Dr. Frank Laukien and his half-brother, Dr. Dirk Laukien (collectively, the Laukien Trust). The purchase
price was allocated between the two building as follows: $5.6 million for 15 Fortune Drive and $6.7 million for 44 Manning Road. The price for the properties was based on an independent third-party appraisal and arms-length negotiations with the sellers. Prior to the acquisition of the property, Bruker BioSpin Corporation leased the property at 15 Fortune Drive from the Laukien Trust; in 2020, Bruker BioSpin
Corporation paid $82,402 in rent to the Laukien Trust.
Dr. Dirk Laukien (half-brother of Dr. Frank Laukien), Mr. Joerg
Laukien (brother of Dr. Frank Laukien), and Ms. Laukien-Kleiner (the stepmother of Dr. Frank Laukien) are co-owners of ZeroC Project GmbH (ZeroC), which rents two
properties located in Fallanden, Switzerland to Bruker BioSpin AG:
|
|
|
Pursuant to the Lease Agreement, dated January 1, 2009, Bruker BioSpin AG paid $218,169 in rent to ZeroC for
the property located at Tamperlistrasse 8 in 2020.
|
|
|
|
Pursuant to the Lease Agreement, dated June 1, 2012, Bruker BioSpin AG paid $13,319 in rent to ZeroC for the
roof terrace offices located at Tamperlistrasse 8 in 2020.
|
Isolde Laukien and Dirk Laukien co-own another property in Fallanden, Switzerland, which is rented to Bruker BioSpin AG. Isolde Laukien owns 75% of the property and Dirk Laukien owns 25%.
|
|
|
Pursuant to the Lease Agreement, dated May 24, 2000, Bruker BioSpin AG paid $525,527 in rent to Isolde
Laukien and Dirk Laukien for the property located at Industriestrasse 12 in 2020.
|
Payments under the terms of each of
the foregoing leases were equal to the estimated fair market value of the respective rental. The disclosed rent amounts are based on actual payments in Swiss Francs converted to U.S. Dollars at a conversion rate of CHF 1.0 =$1.0661, which represents
the 2020 average midpoint rate.
Dr. Dirk Laukien, half-brother of Dr. Frank Laukien, is the sole owner of QA Group, LLC DBA
Quantum Analytics, an analytical equipment leasing business. In 2020, Quantum Analytics purchased $639,538 in equipment from Bruker to lease to third parties. All sales to Quantum Analytics were made in the ordinary course of business and comparable
to those that would have been reached by unrelated parties in arms-length transactions.
Dr. Gilles Martin, a director of Bruker until the 2020 annual meeting held on May 21, 2020, was and remains the Chairman, Chief
Executive Officer and controlling shareholder of the Eurofins Scientific Group, a provider of analytical testing services, and a director of various of its affiliates. During the period of Mr. Martins directorship in 2020, we received
approximately $151,326 from, and paid approximately $21,046 to, entities affiliated with the Eurofins Scientific Group in connection with purchases and sales of goods and services entered into in the normal course of business. We believe that the
terms of such transactions are comparable to those that would have been reached by unrelated parties in arms-length transactions.
Dr. Meike Hamester, the wife of Juergen Srega, the President of Bruker CALID Group, is employed by our Bruker Daltonik GmbH subsidiary as
the Director of Small Molecule Pharma & CRO. During 2020, Dr. Hamester received a base salary in the amount of $109,540 and earned an annual performance-based cash incentive bonus of $28,077. She also received a bonus payment in the
amount of $24,653 which was earned in 2019 but paid in 2020. Dr. Hamesters base salary and bonus are payable in Euros; amounts are converted to U.S. Dollars at a conversion rate of 1.0=$1.14136, which represents the 2020 average
midpoint rate. Her compensation is consistent with the total compensation provided to other employees of the same level with similar responsibilities and experience. Dr. Hamester continues to be an employee of Bruker Daltonik GmbH and she may
receive compensation and other benefits in 2021 in amounts similar to those she received during 2020.
55